Subhash Gumber
Gastroenterology · Cary, NCNPI 1205975398
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $96,860 of the $130,464 with a category attached, or 74.2%. Sanofi accounts for 78.6% of it on its own, with 27 other manufacturers making up the rest. 2023 is the largest year on record at $72,705, more than ten times the $1,807 reported in 2019. Among gastroenterology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 394 payments — averaging $331.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$102K
- Regeneron Healthcare Solutions, Inc.$21K
- AbbVie$2K
- Micro-tech Endoscopy USA, Inc.$900
- Pfizer$610
- Takeda Pharmaceuticals U.S.A., Inc.$542
- plus $3K from 22 others
Across 14 payments — averaging $2623.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Adare Pharmaceuticals, Inc.$13K
- Gilead$10K
- Ironwood Pharmaceuticals, Inc$10K
- Braintree Laboratories, Inc.$4K
What the payments were for
- Consulting fees$3,5203%
- Speaking & faculty fees$96,86074%
- Travel & lodging$22,05217%
- Food & beverage$7,9326%
- Education$1000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 75 | $102,488 |
| Regeneron Healthcare Solutions, Inc. | 20 | $21,470 |
| AbbVie(2 entities) | 92 | $1,756 |
| Micro-tech Endoscopy USA, Inc. | 1 | $900 |
| Pfizer | 43 | $610 |
| Takeda Pharmaceuticals U.S.A., Inc. | 36 | $542 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 26 | $485 |
| Johnson & Johnson(2 entities) | 21 | $402 |
| E.r. Squibb & Sons, L.L.C. | 3 | $362 |
| Janssen Scientific Affairs, LLC | 2 | $212 |
| Intercept Pharmaceuticals, Inc. | 11 | $174 |
| Nestle Healthcare Nutrition Inc. | 9 | $173 |
| Gilead | 10 | $159 |
| Ferring Pharmaceuticals Inc. | 6 | $108 |
| Daiichi Sankyo Inc. | 6 | $107 |
| Bristol Myers Squibb | 6 | $105 |
| UCB, Inc. | 3 | $67 |
| Merck | 4 | $61 |
| Braintree Laboratories, Inc. | 4 | $50 |
| Redhill Biopharma Inc. | 3 | $47 |
| Shionogi Inc | 3 | $44 |
| Ironwood Pharmaceuticals, Inc | 2 | $29 |
| Ardelyx, Inc. | 2 | $26 |
| QOL Medical, LLC | 2 | $23 |
| Amgen | 1 | $20 |
| Shire North American Group Inc | 1 | $17 |
| Intra-sana Laboratories | 1 | $14 |
| GSK | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$130,464 in reported general payments places this provider in the 95th percentile of 610 gastroenterology providers in North Carolina.
Other gastroenterology in Cary
- Christopher McGowanCary$223K
- Nidhi MalhotraCary$156K
- Stephen DealCharlotte$945K
- Fred FowlerCharlotte$932K
- Paul WatkinsChapel Hill$876K
- Nilesh LodhiaCharlotte$735K
- Evan DellonChapel Hill$431K
- Robert ReindollarSalisbury$430K
- Andrew StormWinston Salem$426K
- John PoulosFayetteville$407K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.